CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine - Archive ouverte HAL Access content directly
Journal Articles Blood Advances Year : 2018

CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine

Abstract

Key Points Ara-C is the mainstay of treatment for patients with AML, and life-threatening toxicities are common. We demonstrated that cytidine deaminase downregulation predicts severe/lethal toxicities with cytarabine.
Fichier principal
Vignette du fichier
462.full.pdf (1.13 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

hal-01770057 , version 1 (18-04-2018)

Identifiers

Cite

Raphaelle Fanciullino, Laure Farnault, Mélanie Donnette, Diane-Charlotte Imbs, Catherine Roche, et al.. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine. Blood Advances, 2018, 2 (5), pp.462 - 469. ⟨10.1182/bloodadvances.2017014126⟩. ⟨hal-01770057⟩
137 View
107 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More